A model for developing a decision support system to simulate national drug policy indicators

A model for developing a decision support system to simulate national drug policy indicators

Bibliographic Details
Main Authors:	Abdollahiasl, Akbar, Nikfar, Shekoufeh, Kebriaeezadeh, Abbas, Dinarvand, Rasoul, Abdollahi, Mohammad
Format:	Online
Language:	English
Published:	Termedia Publishing House 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258808/

Similar Items

A system dynamics model for national drug policy
by: Abdollahiasl, Akbar, et al.
Published: (2014)

Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran
by: Nikfar, Shekoufeh, et al.
Published: (2005)

Cost-effectiveness of adding-on new antiepileptic drugs to conventional regimens in controlling intractable seizures in children
by: Gharibnaseri, Zahra, et al.
Published: (2012)

Pharmaceutical supply chain risks: a systematic review
by: Jaberidoost, Mona, et al.
Published: (2013)

Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing countries
by: Kebriaeezadeh, Abbas, et al.
Published: (2013)

Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments
by: Nikfar, Shekoufeh, et al.
Published: (2013)

Assessment of the vaccine industry in Iran in context of accession to WTO: a survey study
by: Hashemi Meshkini, Amir, et al.
Published: (2012)

Consistent defined threshold and equity in health
by: Nikfar, Shekoufeh, et al.
Published: (2015)

Pharmaceutical market and health system in the Middle Eastern and Central Asian countries: Time for innovations and changes in policies and actions
by: Abdollahias, Akbar, et al.
Published: (2011)

Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies
by: Rezvanfar, Mohammad Ali, et al.
Published: (2013)

A systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experience
by: Keshavarz, Khosro, et al.
Published: (2013)

Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancer
by: Hashemi-Meshkini, Amir, et al.
Published: (2013)

From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?
by: Hashemi-Meshkini, Amir, et al.
Published: (2014)

The place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysis
by: Rezaie, Ali, et al.
Published: (2010)

Is Certolizumab Pegol Safe and Effective in the Treatment of Patients with Moderate to Severe Crohn’s Disease? A Meta-analysis of Controlled Clinical Trials
by: Nikfar, Shekoufeh, et al.
Published: (2013)

Efficacy and tolerability of renzapride in irritable bowel syndrome: a meta-analysis of randomized, controlled clinical trials including 2528 patients
by: Mozaffari, Shilan, et al.
Published: (2014)

Are probiotics effective in management of irritable bowel syndrome?
by: Hosseini, Asieh, et al.
Published: (2012)

Current opinion on treatment of inflammatory bowel disease in pregnant women
by: Salari, Pooneh, et al.
Published: (2012)

A Comprehensive Review of Clinical Trials on EGFR Inhibitors Such as Cetuximab and Panitumumab as Monotherapy and in Combination for Treatment of Metastatic Colorectal Cancer
by: Yazdi, Mohammad Hossein, et al.
Published: (2015)

Code of ethics for the national pharmaceutical system: Codifying and compilation
by: Salari, Pooneh, et al.
Published: (2013)

A meta-analysis on the efficacy and tolerability of natalizumab in relapsing multiple sclerosis
by: Nikfar, Shekoufeh, et al.
Published: (2010)

Financial perspective of private pharmacies in Tehran (Iran); is it a lucrative business?
by: Keshavarz, Khosro, et al.
Published: (2012)

Pharmacists Remuneration Models in Iran and Selected Countries: a Comparative Study
by: Hashemi-Meshkini, Amir, et al.
Published: (2013)

A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease
by: Ehteshami-Afshar, Solmaz, et al.
Published: (2011)

Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysis
by: Nikfar, Shekoufeh, et al.
Published: (2012)

Commercialization of biopharmaceutical knowledge in Iran; challenges and solutions
by: Nassiri-Koopaei, Nasser, et al.
Published: (2014)

“Annual Pharma Statistics” as a Health Information System Application in Iranian Pharmaceutical Sector
by: Farshchi, Amir, et al.
Published: (2015)

Challenges of access to medicine and the responsibility of pharmaceutical companies: a legal perspective
by: Ahmadiani, Saeed, et al.
Published: (2016)

Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple additive weighting (SAW) methods
by: Jaberidoost, Mona, et al.
Published: (2015)

A Cost-Utility and Cost-Effectiveness Analysis of Different Oral Antiviral Medications in Patients With HBeAg-Negative Chronic Hepatitis B in Iran: An Economic Microsimulation Decision Model
by: Keshavarz, Khosro, et al.
Published: (2016)

A Stability-Indicating HPLC Method for the Determination of Fingolimod in Pharmaceutical Dosage Forms
by: Souri, Effat, et al.
Published: (2015)

Evaluation of prescriptions of medicines not included in Iran medicine list: A cross-sectional study
by: Zargaran, Marzieh, et al.
Published: (2016)

Assessing the effectiveness and cost-effectiveness of audit and feedback on physician’s prescribing indicators: study protocol of a randomized controlled trial with economic evaluation
by: Soleymani, Fatemeh, et al.
Published: (2012)

Simulation based decision support system for optimization
by: Mohammad Asif, Salam, et al.
Published: (2016)

Acknowledgement of manuscript reviewers 2014
by: Abdollahi, Mohammad, et al.
Published: (2015)

Economic Burden of Hepatitis B Virus-Related Diseases: Evidence From Iran
by: Keshavarz, Khosro, et al.
Published: (2015)

The Effects of Financial Support Policies on Corporate Decisions by SMEs
by: NAM, CHANG WOO
Published: (2016-08-01)

Competitiveness and national policies
by: Abbas J., Ali
Published: (2011)

Assessing national policies to support software in Europe
by: Timo, Leimbach, et al.
Published: (2010)

Determination of Diclofenac on a Dysprosium Nanowire- Modified Carbon Paste Electrode Accomplished in a Flow Injection System by Advanced Filtering
by: Daneshgar, Parandis, et al.
Published: (2009)